Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency | BMJ Case Reports
Prolia® (denosumab) vs zoledronic acid Study Design | Prolia®
Nutrients | Free Full-Text | Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients
Safety, Efficacy, & Side Effects | Prolia® (denosumab)
Denosumab - Wikipedia
Denosumab - ICID - Salisbury NHS Foundation Trust
Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: a short-term study | BMC Endocrine Disorders | Full Text
Prolia® (denosumab) Mechanism of Action | Prolia®
Minimizing the risk of hypocalcemia before and during treatment with... | Download Scientific Diagram
How Prolia® Works | Prolia® (denosumab)
Carboxy Terminal Telopeptide - an overview | ScienceDirect Topics
Prolia side effects and how to avoid them - NiceRx
Extreme hypocalcaemia and hyperparathyroidism following denosumab. Is this drug safe in chronic kidney disease? | Nefrología
How Long Can You Take Prolia Injections and Prolia Side Effects
Prolia® (denosumab) Dosing | Prolia®
Should Vitamin D Level be Measured Before Denosumab in Patients with Castration-Resistant Metastatic Prostate Cancer to Prevent
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults | NEJM
IJERPH | Free Full-Text | Efficacy of Denosumab Therapy Following Treatment with Bisphosphonates in Women with Osteoporosis: A Cohort Study
Pharmacy | Free Full-Text | Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases
Frontiers | Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
Prolia® (denosumab) Open-Label Extension Study Design | Prolia®
Prolia: 7 things you should know - Drugs.com
Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment | Bone Research
